Showing results (171-180 of 283) with videos related to

Sort By:
Pageof 29
Seminars in Oncology|June 1, 1995
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancerP Lorigan, S M Lee, D Betticher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
The feasibility of using glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Medical Research Council Lung Cancer Working PartyN Thatcher, H Anderson, N M Bleehen, et al.
British Journal of Diseases of the Chest|January 1, 1984
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerN Thatcher, D Honeybourne, J Wagstaff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase II study of oral topotecan in advanced non-small cell lung cancerS C White, S Cheeseman, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancerE de Campos, J Radford, W Steward, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pumpM Hrubisko, A T Mc Gown, J A Prendiville, et al.
Journal of Skin Cancer|October 29, 2013
Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary teamJ J Cubitt, A A Khan, E Royston, et al.
Cancer|November 15, 1987
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerN Thatcher, T Cerny, R Stout, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
British Journal of Cancer|January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursE Dean, M R Middleton, T Pwint, et al.
Pageof 29